EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

REGADENOSON MYOCARDIAL PERFUSION SCINTIGRAPHY: A SINGLE CENTRE EXPERIENCE

Muhammad Adil, Zaigham Salim Dar, Shahbaz Afsar Khan, Fida Hussain, Asad Malik, Husnain Saleem

Journal of Ayub Medical College Abbottabad · 2024

DOI: 10.55519/jamc-03-13734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayub Medical College Abbottabad, 2024. Verfasst von Muhammad Adil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medical Centre, Armed Forces Institute of Pathology, Rawalpindi-Pakistan. Hauptthemen laut MEDLINE: Purines, Myocardial Perfusion Imaging, Pyrazoles. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Regadenoson is highly selective A2A adenosine receptors agonist used for stress myocardial perfusion scintigraphy. This study presents our initial experience utilizing Regadenoson as a myocardial perfusion stress agent, aimed to assess the safety of Regadenoson for stress myocardial perfusion scintigraphy.

Methods

Following Institutional Ethical Review Borad approval, adult patients presenting for myocardial stress perfusion scintigraphy were included using non-probability consecutive sampling. Exclusions included second or third-degree AV block, unstable angina, recent myocardial infarction, severe hypotension, or significant heart failure. Demographic data, co-morbidities, vitals, and adverse events were recorded.

Results

Sixty-three patients were included, predominantly male (63.5%), with a mean age of 56.81±12.95 years. Hyperlipidaemia was the most common co-morbidity (47.6%). Systolic and diastolic blood pressure decreased acutely but normalised by 60 minutes. No serious adverse effects occurred, though transient ST segment depression was noted in 8.3% of patients. The most common adverse effects were dyspnoea (23.8%) and headache (21.4%).

Conclusion

Regadenoson is associated with transient haemodynamic changes and non-serious transient adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PurinesMyocardial Perfusion ImagingPyrazolesHumansMaleFemaleMiddle AgedAgedAdenosine A2 Receptor AgonistsAdult

Stichwörter der Autor:innen

Coronary artery disease; Myocardial perfusion imaging; Regadenoson

Substanzen

regadenosonPurinesPyrazolesAdenosine A2 Receptor Agonists

Autor:innen und Institutionen

  • Nuclear Medical Centre, Armed Forces Institute of Pathology, Rawalpindi-Pakistan.
  • Combined Military Hospital Abbottabad-Pakistan.

Zitieren

APA

Adil, M., Dar, Z. S., Khan, S. A., Hussain, F., Malik, A., & Saleem, H. (2024). REGADENOSON MYOCARDIAL PERFUSION SCINTIGRAPHY: A SINGLE CENTRE EXPERIENCE. Journal of Ayub Medical College Abbottabad. https://doi.org/10.55519/jamc-03-13734

Vancouver

Adil M, Dar ZS, Khan SA, Hussain F, Malik A, Saleem H. REGADENOSON MYOCARDIAL PERFUSION SCINTIGRAPHY: A SINGLE CENTRE EXPERIENCE. Journal of Ayub Medical College Abbottabad. 2024. doi:10.55519/jamc-03-13734

BibTeX
@article{Adil2024,
  author = {Adil, Muhammad and Dar, Zaigham Salim and Khan, Shahbaz Afsar and Hussain, Fida and Malik, Asad and Saleem, Husnain},
  title = {REGADENOSON MYOCARDIAL PERFUSION SCINTIGRAPHY: A SINGLE CENTRE EXPERIENCE},
  journal = {Journal of Ayub Medical College Abbottabad},
  year = {2024},
  doi = {10.55519/jamc-03-13734}
}
Kostenlos starten →